Price of generic cycloserine in India

Cycloserine (Cycloserine) is an antibiotic, mainly used to treat tuberculosis, especially tuberculosis strains that are resistant to other anti-tuberculosis drugs. The molecular formula of cycloserine isC3H6N2O2, and its structural feature is that it contains a cyclic serine.

Cycloserine is currently on the market in China and has been included in medical insurance. Patients can purchase it domestically. The domestic drug250mg*10 tablets is about a few hundred yuan. For specific prices and medical insurance reimbursement prices, please consult the local hospital pharmacy. The cheaper ones abroad are Indian generic drugs. The price of 250mg*60 tablets is about 600 yuan, and the ingredients are basically the same as those of domestic drugs.

The main mechanism of action of cycloserine is to inhibit the synthesis of the cell wall of Mycobacterium tuberculosis. It prevents bacterial cell wall formation by competitively inhibiting two important enzymes - D-alanyl synthase and D-alanine ligase. This makes the bacteria unable to maintain its structure and survival, thereby achieving the effect of inhibiting and killing bacteria.

In addition to the treatment of tuberculosis, cycloserine is also used to treat some other infections, but its application is more limited because its use requires strict monitoring. One of the special features of cycloserine is its ability to penetrate the blood-brain barrier, so it also has potential applications in certain neurological infections.

Cycloserine should be used with caution because it has many side effects. Common side effects include headache, insomnia, irritability, depression, and neurological symptoms such as seizures. These neurotoxic effects may be more severe at high doses or with long-term use. Therefore, the use of cycloserine usually requires blood concentration monitoring and dose adjustment based on the patient's specific conditions.

Although cycloserine plays an important role in anti-tuberculosis treatment, due to its side effects and drug resistance issues, scientists are still constantly researching and developing new anti-tuberculosis drugs in order to find more effective and safer alternatives.